文献速递泌尿生殖腹部MRPET

多参数MRI与68Ga-PSMA-11 PET/MRI对前列腺癌包膜外侵犯和精囊侵犯诊断准确性的比较

Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer.
PubMed 文献 · Radiology · 2019-09-10

回顾性分析40例疑诊前列腺癌患者,比较四种读者盲法判读多参数MRI与68Ga-PSMA-11 PET/MRI对包膜外侵犯和精囊侵犯的诊断准确性。结果显示PET/MRI在患者层面包膜外侵犯检测敏感度更高(69% vs 46%,P=0.04),但区域层面特异度略低(90% vs 94%,P=0.007),总体两种方法对中高危前列腺癌局部 staging 表现相似。

要点

  • PET/MRI在患者层面对包膜外侵犯的敏感度高于多参数MRI(69% vs 46%,P=0.04),但特异度无显著差异(67% vs 75%,P=0.19)。
  • 区域层面PET/MRI对包膜外侵犯特异度略低于多参数MRI(90% vs 94%,P=0.007)。
  • 两种方法对精囊侵犯的诊断准确性和读者间一致性均无显著差异。

核心结论

  • 对于中高危前列腺癌患者的局部 staging,68Ga-PSMA-11 PET/MRI与多参数MRI表现相似;PET/MRI检测包膜外病变的敏感度提高,但代价是特异度略降低。

研究设计与样本

  • 回顾性分析2016年4月至2018年7月间40例连续男性患者,均在6个月内接受多参数MRI和68Ga-PSMA-11 PET/MRI检查,随后行根治性前列腺切除术。

关键影像表现/征象

  • 四种读者使用五点Likert量表盲法评估包膜外侵犯和精囊侵犯的概率。
  • 以根治性前列腺切除标本作为参考标准。
  • 采用多读者多病例分析计算读者平均AUC、敏感度和特异度。
  • 读者间一致性采用Fleiss多读者κ评估。

诊断标准与关键数值

  • 区域层面包膜外侵犯检测:多参数MRI vs PET/MRI的AUC为0.67 vs 0.75(P=0.07),敏感度28%(21/76) vs 47%(36/76)(P=0.09),特异度94%(529/564) vs 90%(509/564)(P=0.007)。
  • 患者层面包膜外侵犯检测:AUC 0.66 vs 0.73(P=0.19),敏感度46%(22/48) vs 69%(33/48)(P=0.04),特异度75%(84/112) vs 67%(75/112)(P=0.19)。
  • 区域层面精囊侵犯检测:AUC 0.66 vs 0.74(P=0.21),敏感度35%(7/20) vs 50%(10/20)(P=0.25),特异度98%(295/300) vs 94%(282/300)(P<0.001)。
  • 患者层面精囊侵犯检测:AUC 0.65 vs 0.79(P=0.25),敏感度35%(7/20) vs 55%(11/20)(P=0.20),特异度98%(137/140) vs 94%(131/140)(P=0.07)。
  • 读者间一致性:包膜外侵犯κ 0.46 vs 0.40(P=0.24),精囊侵犯κ 0.23 vs 0.33(P=0.39)。

临床应用与阅片要点

  • PET/MRI检测包膜外侵犯的敏感度更高,但区域层面特异度略低(90% vs 94%,P=0.007)。
  • 患者层面PET/MRI对包膜外侵犯的敏感度高于多参数MRI(69% vs 46%,P=0.04),特异度无显著差异(67% vs 75%,P=0.19)。
  • 两种方法对精囊侵犯的诊断准确性均无显著差异。
  • 两种方法的读者间一致性均仅为中等(κ 0.23–0.46),且无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Recent studies have reported the additive value of combined gallium 68 (68Ga)-labeled Glu-urea-Lys (Ahx)-HBED-CC ligand targeting the prostate-specific membrane antigen (PSMA) (hereafter called 68Ga-PSMA-11) PET/MRI for the detection and localization of primary prostate cancer compared with multiparametric MRI. Purpose To compare the diagnostic accuracy and interrater agreement of multiparametric MRI and 68Ga-PSMA-11 PET/MRI for the detection of extracapsular extension (ECE) and seminal vesicle infiltration (SVI) in patients with prostate cancer. Materials and Methods Retrospective analysis of 40 consecutive men who underwent multiparametric MRI and 68Ga-PSMA-11 PET/MRI within 6 months for suspected prostate cancer followed by radical prostatectomy between April 2016 and July 2018. Four readers blinded to clinical and histopathologic findings rated the probability of ECE and SVI at multiparametric MRI and PET/MRI by using a five-point Likert-type scale. The prostatectomy specimen served as the reference standard. Accuracy was assessed with a multireader multicase analysis and by calculating reader-average areas under the receiver operating characteristics curve (AUCs), sensitivity, and specificity for ordinal and dichotomized data in a region-specific and patient-specific approach. Interrater agreement was assessed with the Fleiss multirater κ. Results For multiparametric MRI versus PET/MRI in ECE detection, respectively, AUC, sensitivity, and specificity in the region-specific analysis were 0.67 and 0.75 (P = .07), 28% (21 of 76) and 47% (36 of 76) (P = .09), and 94% (529 of 564) and 90% (509 of 564) (P = .007). For the patient-specific analysis, AUC, sensitivity, and specificity were 0.66 and 0.73 (P = .19), 46% (22 of 48) and 69% (33 of 48) (P = .04), and 75% (84 of 112) and 67% (75 of 112) (P = .19), respectively. For multiparametric MRI versus PET/MRI in SVI detection, respectively, AUC, sensitivity, and specificity of the region-specific analysis were 0.66 and 0.74 (P = .21), 35% (seven of 20) and 50% (10 of 20) (P = .25), and 98% (295 of 300) and 94% (282 of 300) (P < .001). For the patient-specific analysis, AUC, sensitivity, and specificity were 0.65 and 0.79 (P = .25), 35% (seven of 20) and 55% (11 of 20) (P = .20), and 98% (137 of 140) and 94% (131 of 140) (P = .07), respectively. Interrater reliability for multiparametric MRI versus PET/MRI did not differ for ECE (κ, 0.46 vs 0.40; P = .24) and SVI (κ, 0.23 vs 0.33; P = .39). Conclusion Our results suggest that gallium 68 (68Ga)-labeled Glu-urea-Lys (Ahx)-HBED-CC ligand targeting the prostate-specific membrane antigen (PSMA) (68Ga-PSMA-11) PET/MRI and multiparametric MRI perform similarly for local staging of prostate cancer in patients with intermediate-to-high-risk prostate cancer. The increased sensitivity of 68Ga-PSMA-11 PET/MRI for the detection of extracapsular disease comes at the cost of a slightly reduced specificity. © RSNA, 2019.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Muehlematter UJ, Burger IA, Becker AS, et al. Diagnostic Accuracy of Multiparametric MRI versus 68Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer. Radiology. 2019. PMID: 31502937. doi:10.1148/radiol.2019190687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。